Menu
You need to sign in or sign up before continuing.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Got a PPP Loan for Your Business? Here Are 3 Updates You Need to Know About
Got a PPP Loan for Your Business? Here Are 3 Updates You Need to Know About

Small businesses across the country have been struggling since March, when COVID-19 really took hold and many were forced to close their doors or change their business models. Thankfully, the

Should Sorrento Therapeutics Be Your Next Coronavirus Buy?
Should Sorrento Therapeutics Be Your Next Coronavirus Buy?

Sorrento Therapeutics (NASDAQ: SRNE) had good news for investors recently when it said its second candidate to fight coronavirus showed positive results in preclinical testing. That's after positive

Where Will Phillips 66 Be in 10 Years?Photo, wide shot, wide-angle lens,  Gas company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/01083d82-021d-4573-8c40-0e836a0771d6.png
Where Will Phillips 66 Be in 10 Years?

There may be more disruption taking place in the oil and gas industry today than at any time in the past 100 years. COVID-19 caused such a disruption in oil markets that oil futures prices went

Is Synchrony Financial a Buy While It's Down?
Is Synchrony Financial a Buy While It's Down?

Synchrony Financial (NYSE: SYF), the financial institution that specializes in store-branded credit cards, was one of the most beaten-down stocks as the COVID-19 pandemic caused the U.S. economy to

So You Want To Be A Doctor? Take These 3 Steps First
So You Want To Be A Doctor? Take These 3 Steps First

It's no secret why young people everywhere aspire to become doctors. Society holds doctors in high esteem thanks to their lifesaving and life-prolonging services, their compassion, their scientific

45% of Workers Plan to Ease Into Retirement, and Here's Why You May Want to Do the Same
45% of Workers Plan to Ease Into Retirement, and Here's Why You May Want to Do the Same

For some people, the transition from working to retirement is effectively a hard stop -- one day you're plugging away for eight hours at your desk, the next day you're a person of leisure whose days

The 1 Stock I'd Buy Right Now
The 1 Stock I'd Buy Right Now

I could pretty easily rattle off the names of at least 20 stocks that I think will be long-term winners. But if you asked me to narrow the list down to just the top three, it would take me a while

If You Invested $5,000 in Canopy Growth's IPO, This Is How Much Money You'd Have Now
If You Invested $5,000 in Canopy Growth's IPO, This Is How Much Money You'd Have Now

Not every company can start out with the biggest market cap in its industry. But Canopy Growth (NYSE: CGC) did. How? It was the first publicly traded Canadian cannabis producer. And Canopy still

Buying These 3 Stocks Is a Brilliant Move to Make Right Now
Buying These 3 Stocks Is a Brilliant Move to Make Right Now

Should I buy stocks? Should I hold off? Those are the questions that are probably going through may investors' minds right now. After the big stock market rebound over the last three months, it's

Could Gilead Sciences Have an HIV Cure Waiting in the Wings?
Could Gilead Sciences Have an HIV Cure Waiting in the Wings?

Most of the buzz over Gilead Sciences (NASDAQ: GILD) in recent months has centered on its antiviral drug remdesivir. That's understandable, considering that the drug is currently the most promising

What's the Outlook for Moderna?
What's the Outlook for Moderna?

It's probably fair to say that no one in late 2019 would have foreseen the crazy ride that Moderna (NASDAQ: MRNA) has had so far this year. Global pandemics aren't all that easy to predict.

Moderna

3 Top Dividend Stocks to Buy Right Now
3 Top Dividend Stocks to Buy Right Now

It's an interesting time in the stock markets to say the least. The S&P 500 is up 9% in the past three months, nearly making up for the crash that happened in March.

Despite millions of Americans

3 Pot Stocks to Stay Miles Away From
3 Pot Stocks to Stay Miles Away From

Tilray (NASDAQ: TLRY), HEXO (NYSE: HEXO), and MediPharm Labs (OTC: MEDIF) are three Canadian companies that have been popular cannabis stocks, but there are good reasons to avoid investing in them

Which Stock Will Bounce Back Best: Medtronic or Boston Scientific?Photo, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Which Stock Will Bounce Back Best: Medtronic or Boston Scientific?

The medical device sector took a hit this spring when patients were forced to postpone elective surgical procedures due to the coronavirus pandemic, and Medtronic (NYSE: MDT) and Boston Scientific

Nearly 58% of Workers Think Investing in Stocks Is a Good Idea Right Now. Here's Why They're Right.
Nearly 58% of Workers Think Investing in Stocks Is a Good Idea Right Now. Here's Why They're Right.

Though the U.S. economy may be in a recession, the stock market, right now, seems to say otherwise. As of June 10, the S&P 500 was up nearly 1,000 points since its low in late March, and while

Who Can Donate Plasma for COVID-19 Patients?
Who Can Donate Plasma for COVID-19 Patients?

People who had COVID-19 and are now fully recovered may be eligible to donate plasma to help patients currently infected with COVID-19. Their plasma likely contains antibodies that bind and inhibit

Donald Trump's Stimulus Plan Is a Double-Edged Sword
Donald Trump's Stimulus Plan Is a Double-Edged Sword

Over the past three-plus months, Americans have been challenged like never before. The coronavirus disease 2019 (COVID-19) pandemic has pushed the unemployment rate from near a 50-year low of sub-4%

Better Buy: CRISPR Therapeutics vs. Sangamo TherapeuticsPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Better Buy: CRISPR Therapeutics vs. Sangamo Therapeutics

CRISPR Therapeutics (NASDAQ: CRSP) and Sangamo Therapeutics (NASDAQ: SGMO) are clinical-stage biotech companies aiming to capture a slice of the cell and gene therapy market, which will grow to be

2 Cannabis Stocks That Should Survive the COVID-19 Crisis
2 Cannabis Stocks That Should Survive the COVID-19 Crisis

What's essential for businesses when a crisis like the COVID-19 pandemic hits is to keep operating and try to make it out of the crisis without running out of money. Almost all the sectors are

4 States Where Legalizing Marijuana Will Have to Wait Until 2021 or 2022
4 States Where Legalizing Marijuana Will Have to Wait Until 2021 or 2022

Despite all that's gone on in 2020, it's important not to lose sight of the fact that we're now less than five months away from Election Day. We'll see voters choose who'll be president of the

Did You Sell Carnival, Royal Caribbean, and Norwegian Cruise Line Stocks Last Week?
Did You Sell Carnival, Royal Caribbean, and Norwegian Cruise Line Stocks Last Week?

Cruise line stocks were big winners during the first week of June. The second week, they didn't fare as well. Shares of Carnival (NYSE: CCL) (NYSE: CUK), Norwegian Cruise Line Holdings (NYSE: NCLH)

44% of Americans Are Worried Small Businesses Won't Survive COVID-19. Do These Things If You Feel the Same.
44% of Americans Are Worried Small Businesses Won't Survive COVID-19. Do These Things If You Feel the Same.

With much of the country beginning to reopen after months of lockdown due to COVID-19, many consumers are celebrating the return of small businesses. But some may not be able to open their doors, or

Want to Keep Your Retirement Plans on Track? Invest During COVID-19
Want to Keep Your Retirement Plans on Track? Invest During COVID-19

To say that the last few months have been a wild ride for investors would be an understatement. The year started out with one of the stock market's worst quarters in history, and investors watched

Better Buy: Lululemon vs. Stitch FixPhoto, wide shot, wide-angle lens,  Home appliance manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/5d70b6df-fa9b-4237-9702-39c36cb1d4f8.png
Better Buy: Lululemon vs. Stitch Fix

Lululemon (NASDAQ: LULU) and Stitch Fix (NASDAQ: SFIX) both weathered the retail apocalypse in unique ways. Lululemon's focus on high-end yoga apparel and community events locked in shoppers, while

These Stocks Would Have Doubled Your Money Last Year
These Stocks Would Have Doubled Your Money Last Year

It's something of a holy grail with investors -- the search for companies that can double your money. While that feat is impressive enough in its own right, it's even harder to find a growth stock